Warning! USB Port Locking Coming Soon. To Learn More About OneDrive Click Here Please.

If you have any Questions Call the HelpDesk at Ext: 4444 for Assistance.



Happy Retirement Bruce!

"Your hard work has earned you the right to rest and relax for the rest of your life. Congratulations on your retiring!"

Mr. Bruce W. Stroever has been the Chief Executive Officer of Musculoskeletal Transplant Foundation (MTF) since 1996 and its and President since 1992. Mr. Stroever has forty years of product development and general management experience in the medical device and orthobiologics fields. Mr. Stroever joined MTF in late 1988 as General Manager. From 1971 to 1988, Mr. Stroever held several positions with Ethicon, Inc., a Johnson & Johnson, Inc. subsidiary. Mr. Stroever has been Chairman of the Board of Directors at Bone Biologics, Corp since 2012. Mr. Stroever serves on the advisory boards for the Department of Bioengineering at UCLA and the New Jersey Organ and Tissue Sharing Network. He served as Director of ProChon Biotech Ltd. He was elected to the Board of Governors of the American Association of Tissue Banks for a three year term in 1999 and subsequently in 2012. Mr. Stroever received his B.E. in Mechanical/Chemical Engineering from Stevens Institute of Technology in 1972 and a Master’s of Science in Bioengineering from Columbia University in 1977.

During his 29-year tenure at MTF, Stroever led the non-profit organization to become the largest tissue bank in the world. Donated human tissues MTF received from more than 120,000 donors have been used to treat more than 8 million patients throughout the U.S. and more than 50 other countries.

"It has been my pleasure and honor to work with more than 1,100 dedicated staff who are all focused on bringing life-changing tissue transplants to patients, and to providing world class service to the donation and transplant communities," said Mr. Stroever. "Moreover, having the opportunity to help bring some degree of comfort to a grieving family through tissue and organ donation has added a dimension to our work here that is hard to find elsewhere in the healthcare field. Our contributions to academic research, which now surpass $50 million, is another way we've been able to fulfill our mission. I know that MTF's new President and CEO will have the privilege of continuing the work we started in 1987."


# Konstantin Ryabenok 2018-06-14 15:20
You will always be remembered for your accomplishments. Thanks for your years of work and dedication to MTF and congrats on your retirement! 8)
JSN Venture is designed by JoomlaShine.com